journal article·2016-11-18Open access

Cerebral Microvascular and Systemic Effects Following Intravenous Administration of the Perfluorocarbon Emulsion Perftoran

Rania Abutarboush, Biswajit Saha, Saad Mullah, Francoise Arnaud, Ashraful Haque, Chioma Aligbe, Georgina Pappas, Charles Auker, Richard McCarron, Paula Moon-Massat, Anke Scultetus

Abstract

Oxygen-carrying perfluorocarbon (PFC) fluids have the potential to increase tissue oxygenation during hypoxic states and to reduce ischemic cell death. Regulatory approval of oxygen therapeutics was halted due to concerns over vasoconstrictive side effects. The goal of this study was to assess the potential vasoactive properties of Perftoran by measuring brain pial arteriolar diameters in a healthy rat model. Perftoran, crystalloid (saline) or colloid (Hextend) solutions were administered as four sequential 30 min intravenous (IV) infusions, thus allowing an evaluation of cumulative dose-dependent effects. There were no overall changes in diameters of small-sized (<50 μm) pial arterioles within the Perftoran group, while both saline and Hextend groups exhibited vasoconstriction. Medium-sized arterioles (50–100 μm) showed minor (~8–9%) vasoconstriction within saline and Hextend groups and only ~5% vasoconstriction within the Perftoran group. For small- and medium-sized pial arterioles, the mean percent change in vessel diameters was not different among the groups. Although there was a tendency for arterial blood pressures to increase with Perftoran, pressures were not different from the other two groups. These data show that Perftoran, when administered to healthy anesthetized rats, does not cause additional vasoconstriction in cerebral pial arterioles or increase systemic blood pressure compared with saline or Hextend.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Hemoglobin structure and function · Nitric Oxide and Endothelin Effects · Traumatic Brain Injury and Neurovascular Disturbances

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

NeuroTrauma Department, Naval Medical Research Center (NMRC), Silver Spring, MD 20910, USA

Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20895, USA

Funding

Defense Health Program

References (23)

Show source-provided references
1. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death—A meta-analysis10.1001/jama.299.19.jrv80007 ↗
2. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes10.1016/j.freeradbiomed.2003.11.030 ↗
3. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery10.1081/BIO-200046659 ↗
4. Activation of plasma complement by perfluorocarbon artificial blood: Prob-able mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis10.1182/blood.V59.6.1299.1299 ↗
5. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: Results of a european phase 3 study10.1097/00000542-200212000-00004 ↗
7. Use of perftoran emulsion to decrease allogeneic blood transfusion in cardiac surgery: Clinical trial10.1080/10731190600683969 ↗
8. Clinical results of perftoran application: Present and future10.1081/BIO-200046654 ↗
9. Winslow, R.M. (2006). Blood Substitutes, Elsevier Academic Press.
10. Impact of oxygenation of bioartificial liver using perfluorocarbon emulsion perftoran on metabolism of human hepatoma C3A cells10.1080/10731190802554380 ↗
11. KEM Laboratories (2012). Perftec: A Blood Substitute with Oxygen Transporting Capacity, KEM Laboratories.
12. Fluid resuscitation for hemorrhagic shock in tactical combat casualty care: Tccc guidelines change 14-01—2 June 2014
13. Effects of N-acetyl-l-cysteine and hyaluronic acid on HBOC-201-induced systemic and cerebral vasoconstriction in the rat10.2174/15701638113109990034 ↗
14. Effects of the oxygen-carrying solution oxyvita C on the cerebral microcirculation and systemic blood pressures in healthy rats10.3390/jfb5040246 ↗
15. Sanguinate’s effect on pial arterioles in healthy rats and cerebral oxygen tension after controlled cortical impact10.1016/j.mvr.2016.06.001 ↗
16. Perfluorocarbon NVX-108 increased cerebral oxygen tension after traumatic brain injury in rats10.1016/j.brainres.2016.01.012 ↗
17. Moon-Massat, P., Mullah, S.H., Abutarboush, R., Saha, B.K., Pappas, G., Haque, A., Auker, C., McCarron, R.M., Arnaud, F., and Scultetus, A. (2015). Cerebral vasoactivity and oxygenation with oxygen carrier M101 in rats. J. Neurotrauma.
18. Microvascular gas embolization clearance following perfluorocarbon administration10.1152/japplphysiol.00719.2002 ↗
19. Reperfusion injury after critical intestinal ischemia and its correction with perfluorochemical emulsion ”perftoran”10.3748/wjg.v11.i45.7084 ↗
20. The use of oxygenated perfluorocarbonic emulsion for initial in situ kidney perfusion10.1016/j.transproceed.2008.03.053 ↗
21. Pial arteriolar responses in mouse-brain revisited10.1161/01.STR.7.3.283 ↗
22. Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin10.1152/ajpheart.00500.2005 ↗
23. Cerebrovascular response to decreased hematocrit: Effect of cell-free hemoglobin, plasma viscosity, and CO210.1152/ajpheart.00077.2003 ↗